Fujian Medical University: Stomach Neoplasms trials

The registry lists 55 Stomach Neoplasms studies with Fujian Medical University as lead sponsor. 15 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 2 8Phase 3 8No phase 38(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction AdenocarcinomaEnrolling by invitationNCT07356466Early Phase 1
• Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric CancerNot yet recruitingNCT07314203Phase 3
• Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Extended Lymphadenectomy Beyond D2 for Locally Advanced Gastric Cancer (FUGES-30)RecruitingNCT06945718
• 3D-4K-ICG Laparoscopic Gastrectomy for Gastric CancerRecruitingNCT06161207Phase 3
• Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric CancerNot yet recruitingNCT05914610Phase 3
• Fruquintinib Plus Irinotecan in the Treatment of Advanced Gastric CancerNot yet recruitingNCT05643677Phase 2
• Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric CancerRecruitingNCT05618821Phase 2
• Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different ImmunotypesNot yet recruitingNCT05610332Phase 3
• Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different GenotypesNot yet recruitingNCT05524974Phase 2
• Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric AdenocarcinomaNot yet recruitingNCT05270824Phase 3
• the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric CancerNot yet recruitingNCT05235932Not applicable
• Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric CancerNot yet recruitingNCT05230771Phase 3
• Indocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric CancerNot yet recruitingNCT04973475Phase 2
• Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric CancerNot yet recruitingNCT04795063Not applicable
• The Safety, Feasibility and Oncological Outcomes of Laparoscopic Completion Total Gastrectomy for Remnant Gastric CancerEnrolling by invitationNCT02792881Not applicable
• Potential Advantages of Robotic Total Gastrectomy in Advanced Middle-Upper Gastric Cancer: A Multicenter Propensity Score Matching AnalysisCompletedNCT06941168
• Assessment of Robotic Versus Laparoscopic Gastrectomy for GC Patients With Intraoperative Technical ComplexityCompletedNCT06752538
• Impact of TTC Following Neoadjuvant Chemotherapy on the Prognosis of LAGCCompletedNCT06696963
• Appraisal of the Modified Cancer Cachexia Index in Locally Advanced Gastric Cancer Patients Undergoing Neoadjuvant ChemotherapyCompletedNCT06689462
• Comparison of Short- and Long-term Efficacy of Robotic Versus Laparoscopic Gastrectomy in High-risk Patients With Gastric Cancer: a Nationwide, Multicentre Cohort StudyCompletedNCT06603272
• Impact of Preoperative VFA on Intraoperative Adverse Events in Patients Undergoing Laparoscopic Radical GastrectomyCompletedNCT06506331
• Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping.CompletedNCT06376773
• Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence RiskCompletedNCT06337279
• Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant ChemotherapyActive, not recruitingNCT06277453
• The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric CancerActive, not recruitingNCT06235164
• Predict 5-Year Survival in Elderly Gastric CancerCompletedNCT06208046
• Intraoperative Adverse Events in Robotic Radical Gastrectomy for Gastric CancerCompletedNCT05999019
• Learning Curve and Optimization of Robotic GastrectomyCompletedNCT05715775
• Effect of Gastric Cancer Specialist Training Program in Laparoscopic Gastric Cancer Surgery（STP-LRG-1）CompletedNCT05585437
• Factors Affecting the Difficulty of Laparoscopic D2 Lymph Node Dissection for Gastric CancerCompletedNCT05585073
• the Optimal Surveillance Frequency for Stage II/III Gastric CancerCompletedNCT05465993
• Using Radiomics to Predict Neoadjuvant Chemotherapy EfficacyCompletedNCT05465512
• Questionnaire Survey of the Advanced Training Program for Laparoscopic Radical GastrectomyCompletedNCT05219539
• The Effect of Immunological Heterogeneity of Tumor Microenvironment in the Prognosis of Gastric CancerStatus unknownNCT04819958
• Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric CancerStatus unknownNCT04778345Not applicable
• IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant ChemotherapyStatus unknownNCT04611997Phase 3
• Indocyanine Green Tracer Using in Laparoscopic Radical Gastrectomy for Locally Advanced Gastric CancerActive, not recruitingNCT04593615Not applicable
• Randomized Controlled Trial on Effect of Lymph Node Mapping by Indocyanine Green Via Submucosal or Subserosal InjectionActive, not recruitingNCT04219332Phase 3
• Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric CancerCompletedNCT04195828Phase 2
• Trials Comparing of HD Versus 4K Laparoscopy for Gastric CancerStatus unknownNCT04010006Not applicable
• Clinical Efficacy Between Robotic and Laparoscopic Total Gastrectomy in Patients With Clinical Stage I Gastric CancerStatus unknownNCT03524300Not applicable
• Robotic Total Gastrectomy for Locally Advanced Proximal Gastric CancerCompletedNCT03524287Not applicable
• The Effect of Postoperative Referred Pain in the Left Shoulder on Short-term Outcomes for Laparoscopic GastrectomyStatus unknownNCT03482609
• Clinical Outcomes of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric CancerCompletedNCT03313700Not applicable
• Clinical Outcomes of Laparoscopic D1 Versus D2 Lymphadenectomy for Elderly Patients With Advanced Gastric CancerStatus unknownNCT03290209Phase 2
• Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node DissectionCompletedNCT03050879Phase 2
• Randomized Controlled Trials on Clinical Outcomes of Totally Laparoscopic Versus Laparoscopy Assisted Total Gastrectomy for Gastric CancerStatus unknownNCT03006263Not applicable
• The Effect of Preoperative Inflammation-based Scores on Postoperative Morbidity and Mortality for Laparoscopic GastrectomyStatus unknownNCT02930291
• The Effect of Preoperative Hemotologic Markers on Postoperative Long-term and Short-term Outcomes for Laparoscopic GastrectomyStatus unknownNCT02930278
• The Safety and Feasibility of Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer After Neoadjuvant ChemotherapyCompletedNCT02902575Not applicable
• Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric CancerStatus unknownNCT02845986Phase 2
• Randomized Controlled Trials on Laparoscopic No. 14v LNS DissectionStatus unknownNCT02789891Not applicable
• Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric CancerStatus unknownNCT02333721Not applicable
• Randomized Controlled Trials Comparing Clinical Outcomes of 3D Versus 2D Laparoscopic Surgery for Gastric CancerCompletedNCT02327481Not applicable
• Prospective Study on Modified Delta-shaped Gastroduodenostomy in Totally Laparoscopic Surgery for Distal Gastric CancerStatus unknownNCT02289183Not applicable